Stay updated on Efficacy of Subcutaneous Semaglutide in NASH Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Subcutaneous Semaglutide in NASH Clinical Trial page.

Latest updates to the Efficacy of Subcutaneous Semaglutide in NASH Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter updates: the HHS Vulnerability Disclosure link was removed, and the revision history shows v3.3.2 removed and v3.3.3 added.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe record history now includes Revision: v3.3.2 and removes Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedA new revision label v3.3.1 was added and the previous revision v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedThe government funding/operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedThe page history shows multiple version updates with changes to study status, recruitment status, and location/contacts information across versions.SummaryDifference0.1%

- Check93 days agoChange DetectedUpgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.SummaryDifference7%

Stay in the know with updates to Efficacy of Subcutaneous Semaglutide in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Subcutaneous Semaglutide in NASH Clinical Trial page.